Cannabis contains 500+ compounds
This includes over 100 cannabinoids wie zum Beispiel THC und CBD, plus aromatic terpenes.
THC causes the “high”, CBD does not, and neither exists in raw flower until heat triggers a reaction called decarboxylation. Understanding this chemistry is the foundation for everything the modern cannabis industry does, from breeding to prescribing.
Ask most people what is inside cannabis and you will hear one word: THC. That makes sense, it is one of the most widely circulated terms associated with the plant, but it barely scratches the surface of what cannabis actually contains. The cannabis plant is one of the most chemically complex organisms in commercial agriculture, and the compounds it produces are the reason a whole European medical industry now exists around it. If you are stepping into that industry, whether as a candidate, a founder or an investor, the chemistry is the vocabulary you cannot skip. Get it right and product labels, lab reports and clinical conversations suddenly make sense.
This is our plain-English guide to what cannabis is actually made of. No hype, no couch-lock clichés, just the science that matters, explained for people who want to work in the sector rather than simply consume its products.
What are cannabinoids? A quick primer
Cannabinoids are the class of chemical compounds that make cannabis pharmacologically interesting. The plant produces more than 100 distinct cannabinoids, and they work by interacting with the human Endocannabinoid-System, a signalling network that helps regulate mood, pain, appetite, sleep and immune response.
Here is a distinction worth learning early, because it separates people who know the industry from people who do not:
🟣 Phytocannabinoids (from the Greek phyton, meaning “plant”) are made by the cannabis plant itself. THC and CBD are the famous two.
🟣 Endocannabinoids (from the Greek endon, meaning “within”) are made inside your own body and act on the same receptors.
🟣 Synthetic cannabinoids are made in a laboratory to mimic the natural versions, and carry very different risk profiles.
When people talk about cannabinoids in a wellness context, they almost always mean the phytocannabinoids. Those are what we will focus on here.
THC vs CBD: the two compounds that get all the attention
Of those phytocannabinoids the plant produces, two dominate the conversation: tetrahydrocannabinol (THC) und cannabidiol (CBD). Understanding the is the single most useful thing a newcomer can learn.
THC is the primary psychoactive compound, responsible for the intoxicating effect commonly associated with cannabis. It can alter perception, mood and motor function, particularly at higher doses. It does this by .
CBD, in its pure form, has no intoxicating effect. Rather than binding strongly to those same receptors, it influences the system more indirectly, which is why it is used widely for calming, anti-inflammatory and wellness applications without producing a high. A für certain severe, treatment-resistant forms von epilepsy.
The two are not rivals. In medical products they are frequently combined, and the ratio between them, often written as something like 10:10 oder 20:1, is one of the first things a prescriber or product developer considers.
🌱 Fun fact:
Your body makes its own cannabinoids. One of them, Anandamid, takes its name from the Sanskrit word ananda, meaning “bliss”. Cannabis did not invent the system it acts on; it simply borrowed the keys.
The raw truth: decarboxylation and why fresh cannabis will not get you high
Here is a fact that surprises almost everyone new to the plant: .
What the plant actually produces are the acidic precursors, tetrahydrocannabinolic acid (THCA) und cannabidiolic acid (CBDA). In this raw state, no matter how much of it you consume. The compound only becomes active through a chemical reaction called , in which heat removes a carboxyl group from the molecule, releasing carbon dioxide and converting THCA into psychoactive THC.
This happens whenever cannabis is exposed to heat: instantly when a flower meets a flame or a vaporiser, and . It is also why you cannot bake an effective edible from untreated flower without gently heating it first. For anyone working in extraction, formulation or quality control, decarboxylation is not trivia; es ist a controlled processing step dass determines whether a product works als labelled.
Beyond THC and CBD: the minor cannabinoids worth watching
THC and CBD dominate the conversation, but a handful of minor cannabinoids are attracting serious commercial and research interest. These are the compounds that product development teams are quietly betting on for the next wave of formulations.
🟣 CBG (cannabigerol) is often called the “mother cannabinoid” because other cannabinoids are synthesised from its acidic form. Early research points to anti-inflammatory and neuroprotective potential, and a found a single 20mg dose reduced anxiety in healthy adults without any intoxication.
🟣 CBN (cannabinol) forms as THC ages and breaks down. It is widely marketed for sleep, though a found the human evidence for that claim remains thin.
🟣 CBC (cannabichromene) is non-intoxicating and, by some measures, . Preclinical work suggests anti-inflammatory and mood-related effects.
Aside from those three, the plant produces dozens more that most people have never heard of: THCV (tetrahydrocannabivarin), CBDV (cannabidivarin), CBL (cannabicyclol), CBT (cannabitriol), CBE (cannabielsoin), CBGV (cannabigerovarin), THCP (tetrahydrocannabiphorol), CBDP (cannabidiphorol), Delta-8-THC und Delta-10-THC, alongside the acidic precursors THCA, CBDA und CBGA. Over 100 cannabinoids have been , and new ones are still being isolated in laboratories today.
A word of honesty that most cannabis blogs skip: the science has not caught up with the marketing. A found only a single qualifying clinical study across all of them combined. The potential is real, but so is the gap between a promising preclinical result and a proven human benefit. That gap is precisely where credible European operators can differentiate themselves.
🌱 Fun fact:
CBN is not something the plant sets out to make. It is essentially “aged” THC, the cannabinoid equivalent of a wine developing character in the cellar. Old, poorly stored cannabis is often high in CBN, which is why it makes people sleepy rather than high.
Terpenes: the aroma engine of cannabis
If cannabinoids explain the pharmacology of cannabis (the science of how the plant’s compounds interact with the body), terpenes explain its personality. These are the , and they are not unique to it. The same molecules give lavender, citrus peel and pine forests their distinctive scents.
The cannabis plant produces , and it is a strain’s specific terpene profile, , that gives it a recognisable aroma. Here are five of the most common, and where else in nature you will meet them.
The 5 terpenes that shape every cannabis strain
Terpenes are the aromatic compounds that give cannabis its smell, flavour and personality. They are not unique to it — the same molecules give lavender, citrus and pine forests their signature scents.
Myrcene
Also found inMango, hops, thyme
Limonene
Also found inLemon and orange peel
Pinene
Also found inPine needles, rosemary
Linalool
Also found inLavender
Caryophyllene
Also found inBlack pepper, cloves
One more piece of vocabulary. When terpenes undergo a chemical change, . The terms are often used interchangeably, but strictly speaking terpenes are the fresh, natural form and terpenoids are the modified version. Preserving that delicate terpene profile is one of the main reasons extraction method matters so much, a subject we cover in our .
The entourage effect: symphony or marketing story?
This brings us to the most talked-about and most contested idea in cannabis chemistry: the entourage effect.
It proposes that cannabinoids and terpenes work better together than in isolation, each modulating the others so that the whole plant produces effects that no single purified compound can replicate. The whole, in other words, is meant to be greater than the sum of its parts. It is the scientific case for full-spectrum products, and it is repeated across the industry as settled fact.
However, it isn’t settled. Some laboratory research suggests terpenes can subtly influence cannabinoid activity, and the most credible piece of new human evidence, a 2024–2025 double-blind crossover study, found that inhaled limonene combined with THC significantly reduced anxiety and paranoia compared with THC alone. That is a genuine data point in the theory’s favour. But it is one terpene, one cannabinoid and one endpoint. Several other controlled studies have found no meaningful interaction, and a 2025 narrative review reached the same conclusion as its 2024 predecessor: the mechanism is biologically plausible, preclinical results are promising, and clinical translation still lacks the standardised trials needed to confirm it. In other words, the theory may well be real, but “everyone knows it is true” is not the same as “the data confirms it”.
Why does this matter for a professional audience? Because the entourage effect is used to justify premium pricing on full-spectrum products. Knowing that the science is still open, rather than closed, is the difference between marketing a product honestly and overselling it, and in a medical market, that distinction carries regulatory weight.
🌱 Fun fact:
The word “entourage” entered cannabis science through a 1998 paper, but it was popularised by researcher Dr Ethan Russo in a 2011 article memorably titled “Taming THC”. Nearly three decades on, the debate he opened is still very much alive.
Why this chemistry matters for the European cannabis industry
The chemistry of cannabis is the reason so many specialised roles now exist across Europe’s fast-growing medical market:
🟣 Cultivators breed for specific cannabinoid and terpene profiles.
🟣 Extraction technicians choose methods that protect those compounds.
🟣 Quality control teams run potency tests to confirm what a label claims.
🟣 Pharmacists and prescribers weigh THC-to-CBD ratios against a patient’s needs.
Every one of those jobs depends on the foundations we have just covered.
But understanding cannabinoids, decarboxylation and terpenes is only the beginning. From here, the natural next steps are to understand the plant itself, in our guide to cannabis plant anatomy, and how these compounds are physically drawn out, in our guide to cannabis extraction methods.
Frequently asked questions
What is the main difference between THC and CBD?
THC is the intoxicating compound that produces a high by binding directly to receptors in the brain. CBD is non-intoxicating and works more indirectly, which is why it is used for calming and anti-inflammatory purposes without impairment.
Does raw cannabis contain THC?
Not in meaningful amounts. Raw cannabis contains THCA, an acidic precursor that only converts into active THC when heated, through a process called decarboxylation.
What are terpenes and do they get you high?
Terpenes are aromatic compounds that give cannabis its smell and flavour. They are not intoxicating on their own, but they are thought by some researchers to influence the overall effect of a product.
Is the entourage effect proven?
No. It is a widely held and plausible hypothesis, and one 2024–2025 human study on limonene and THC gave it credible new support, but the broader evidence remains mixed and often of low quality. It should be treated as promising rather than established.
What are minor cannabinoids?
These are cannabinoids present in smaller quantities than THC and CBD, such as CBG, CBN und CBC. Several show therapeutic promise in early research, though robust human clinical evidence is still limited.
Referenzen
- Cannabis, a complex plant: over 100 cannabinoids identified (National Library of Medicine)
- (PMC)
- (EMA)
- The endocannabinoid system: an overview (National Library of Medicine)
- CBD vs THC: differences, benefits and effects (Healthline)
- What is decarboxylation, and why does cannabis need it? (Leafly)
- (Journal of Cannabis Research, Springer)
- (Cannabis and Cannabinoid Research)
- Minor cannabinoids explained: CBG, CBN, THCV, CBC and CBDV (The Cannigma)
- Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity (Scientific Reports, Nature)
- The entourage effect in cannabis medicinal products: a comprehensive review (Pharmaceuticals, MDPI, 2024)
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (Russo, British Journal of Pharmacology)
- (Plant Science, ScienceDirect)
- (PMC)
- (Leafwell)
- What is the entourage effect and is it beneficial? (Medical News Today)
- The ‘entourage effect’ — what we don’t know about how cannabis works (The Conversation)
- Phytochemical modulators of nociception: a review of cannabis terpenes in chronic pain syndromes (PMC, 2025)
- (Scientific Reports, Nature, 2024)
- (Cannabis and Cannabinoid Research, 2021)
- (European Neuropsychopharmacology, 2024)
English (UK)
Deutsch